Union Springs Pharmaceuticals, Inc.: Series A $5M

Posted in I - Series A, Q - 3Q09, R - SOUTH EAST, X - Antiinfective, XX - KY

Union Springs Pharmaceuticals (Union, KY) a commercial-stage developer of OTC antiinfective washes for emergency first responders, closed a $5M Series A financing. Participants include Blue Chip Venture Company.

Jun

2009

Xanodyne Pharmaceuticals, Inc.: Series D $38M

Posted in I - Series D, Q - 2Q09, R - SOUTH EAST, X - Menorrhagia, X - Pain, XX - KY

Xanodyne Pharmaceuticals (Newport, KY) an clinical-stage specialty pharmaceutical company focused on pain and menorrhagia, closed a $38M Series D financing. Participants include MPM Capital, AIG Investments, Aisling Capital, Blue Chip Venture Company, Essex Woodlands Health Ventures, HealthCare Ventures and Union Springs Pharmaceuticals.

Mar

2009

Ikano Therapeutics, Inc.: Series B $9M

Posted in I - Series B, Q - 1Q09, R - SOUTH EAST, X - Epilepsy, X - Pain, X - Seizures, XX - KY

Ikano Therapeutics (Lexington, KY) a clinical-stage nasal delivery platform company focused on seizures and pain, closed a $9M Series B financing, the final tranche of a $18M round. Participants include SV Life Sciences, Burrill & Co., Tullis-Dickerson, Fidelity Biosciences, Apjohn Ventures, Fort Washington Capital, Commonwealth Seed Capital and Kentucky Co-Investment Partners.

to top of page...